Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Sterile Tubing Welder Market size was over USD 2.58 billion in 2024 and is projected to exceed USD 5.05 billion by the end of 2037, growing at over 5.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of sterile tubing welder is evaluated at USD 2.69 billion.
The growth of the market can be attributed to the growing concern over the increasing number of blood disorders, and non-cancerous blood diseases worldwide, followed by the need to follow protocols related to sterile and hygienic environments in hospitals and clinical laboratories is increasing. Furthermore, growing concern related to chronic diseases worldwide, increasing the demand for various blood transfusion procedures, is also expected to drive market growth during the forecast period. According to statistics from the Food and Agriculture Organization of the United Nations (FAO), the rate of non-communicable diseases is expected to increase by up to 57% by the end of 2020.
Welding machines are used in biotechnology applications involving larger diameter pipes. The sample is transferred or placed directly into a sterile tube, which must then be tightly sealed and transported to the laboratory for analysis. Growing demand for personalized medicines is a key factor driving the growth of the global sterile tubing welder market.
Sterile Tubing Welder Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Medical Expenditure - One of the main factors driving the global sterile tubing welder market's expansion is the fast-expanding healthcare infrastructure in numerous nations. Because of the increase in cancers, illnesses, and other ailments, governments are already devoting more time and resources to their countries' healthcare systems. The market is expanding as a result of the aging population, and an increase in the prevalence of specific illnesses such as dementia Alzheimer's, and orthopedic disorders. Although proper blood transfusions can enhance health and save lives, many patients lack prompt access to them. The provision of safe, adequate blood must be part of every nation's national healthcare infrastructure and policy.
- Increasing Demand for Blood Products - It is projected that high demand for blood items will drive up the need for sterile processing, blood processing, and related facilities. The market is expected to be driven by the wide-ranging ongoing biopharmaceutical study for the creation of novel and therapeutically advanced medications. These developed medications address a number of important therapeutic areas, including hemophilia, cancer, amyotrophic lateral sclerosis, and genetic disorders, which will help the market expand. A number of products were halted in their manufacturing during the pandemic in 2020, but the pharmaceutical industry led the way in developing new products.
- Increasing Technological Advancements - Many technological advances and equipment purchases that allow for faster turnaround times have been noted. In fact, post-pandemic, we have identified a number of new biopharmaceutical research facilities expected to be established in countries such as Sweden, the Netherlands, Ireland, Scotland, etc. According to the "National Plan on Industrial Biotechnology" Published by IBioIC, a network organization established to promote the biotechnology industry in Scotland, the region is expected to house 220 companies by 2025, with a total workforce Labor is 4,000 people.
Challenges
- Availability of Alternatives – There are a number of alternative methods for sealing sterile tubing, such as heat sealing, ultrasonic sealing, and laser sealing. These methods can be more cost-effective or easier to use than sterile tubing welders, which can limit the growth of the market.
- Strict Regulatory Requirements is Set to Hamper the Market Growth in the Forecast Period.
- Lack of Skilled Labor to Pose Limitation on the Market Expansion in the Upcoming Time Period
Sterile Tube Welder Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.3% |
|
Base Year Market Size (2024) |
USD 2.58 billion |
|
Forecast Year Market Size (2037) |
USD 5.05 billion |
|
Regional Scope |
|
Sterile Tubing Welder Segmentation
Mode (Automatic, Manual)
The automatic segment is predicted to account for 60% share of the global sterile tubing welder market during the forecast period. Considering these welding machines are more user-friendly and produce better welds, the category is expected to continue leading during the projected period. Because automatic welding machines have a significantly greater weld speed than qualified welders, they can be used to set up weld speed and duration without the need for a highly trained professional, which reduces the reliance on human labor. It is therefore expected that the demand for these devices will rise in response to higher output and lower labor expenses.
Application (Component Pooling, Quality Control Pooling, Leukoreduction, Fluid Replacement, Pathogen Reduction, Biopharmaceutical, Cell Washing & Freezing)
The biopharmaceutical segment in the sterile tubing welder market is anticipated to grow significantly by the end of 2037. Reliable component connections are necessary for improved biomanufacturing processes, which call for advanced equipment. Sterile tubing welder usage is increasing in the biopharmaceutical industry, and this is expected to drive robust segment growth over the projected period. Sterile tubing welders are offered by a number of industry leaders for use in biopharmaceutical applications. For example, Sartorius offers an automated device known as the Biowelder TC that is used to sanitize connections between the components of TPE (thermoplastic elastomer) tubes. This time-tested technique uses special spinning tube holders to join dry or liquid-filled TPE tubing. By reconnecting discarded tube ends, ensures that process fluids are completely contained. Sterile Biowelder TC connections are guaranteed via validation processes.
Our in-depth analysis of the global market includes the following segments:
|
Application |
|
|
Mode |
|
|
End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportSterile Tubing Welder Industry - Regional Synopsis
North America Market Forecasts
The sterile tubing welder market in North America region is expected to hold 33% of the revenue share in the forecast period. The rising prevalence of chronic diseases, recent technological advancements, and high demand for hygienic & sterile environments to avoid contamination are some of the key factors contributing to the market growth in this area. The growing burden of chronic diseases in the United States is one of the key factors driving market growth. According to a 2020 National Health Council report, an estimated 157 million people have at least one chronic disease. It is also estimated that 7 out of 10 deaths are due to chronic disease, with kidney failure being one of the leading conditions in the United States.
APAC Market Statistics
The sterile tubing welder market in the Asia Pacific region is set to grow substantially by the end of 2037. The increase in the number of large multinational companies investing in research and development in this region has proven to be a key factor driving the growth of the pharmaceutical and biopharmaceutical industry. Furthermore, the growing aging population and the presence of a large segment of the population belonging to the middle-income group are significantly increasing the demand for innovative and cost-effective aseptic tube welding equipment to attract medical services from leading equipment companies in the region.
Companies Dominating the Sterile Tubing Welder Landscape
- Genesis BPS
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medicaltech Cp., Ltd.
- Sartorius AG
- MGA Technologies
- Global Life Sciences Solutions USA LLC
- Vante Biopharm/Sebra
- Pall Corporation
- Saint-Gobain Performance Plastics
- Sentinel Process Systems Inc.
- GE Healthcare
In the News
- Sartorius completed the acquisition of Albumedix by means of a French listed subsidiary, Sartorius Stedim Biotech, in September 2022.
- April 13, 2018: One of Saint-Gobain Group's subsidiaries, Saint-Gobain Performance Plastics announced that it has acquired the Irish company Micro Hydraulics' pharmaceutical business. The company is known for manufacturing and supplying disposable liquid handling systems and components made of high-performance plastics, which are widely used in the biopharmaceutical and pharmaceutical industries.
Author Credits: Radhika Pawar
- Report ID: 3644
- Published Date: Oct 22, 2024
- Report Format: PDF, PPT
